NCT07021612View on ClinicalTrials.gov

A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Patients With Pure Aortic Regurgitation

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

September 30, 2028

Conditions
Aortic Valve Disease
Interventions
DEVICE

JenaValve

JenaValve is a newly developed advanced TAVI system developed by Jenavalve Technology Inc.

DEVICE

J-Valve

J-Valve is a newly developed advanced TAVI system developed by Genesis Medtech.

Trial Locations (1)

0000

RECRUITING

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Prince of Wales Hospital, Shatin, Hong Kong

OTHER